Interstrand crosslinks (ICLs) are the most toxic lesions in the cell and are known to be effective in cancer treatment. Understanding how ICLs are repaired in cancers will allow us to take advantage of these agents for cancer treatment, to avoid therapy resistance, and to develop biomarkers that can be used to prevent overtreatment for patients who are not responding to these agents. However, despite extensive studies in this area, it remains challenging to come up with a detailed hypothesis and reveal precisely how multiple DNA repair enzymes and pathways act together in ICL repair. This Program Project brings together experts in various aspects of DNA repair pathways and aims at addressing this difficult question. Project 4 focuses on a critical scaffold protein SLX4.
Aim 1 of this project will determine the mechanisms underlying the cell cycle- dependent regulation of SLX4-containing protein complexes and investigate how SLX4 and MSH2 complexes act together to promote ICL repair.
Aim 2 will define mechanistically how SLX4 and SLX4IP are recruited to DNA damage sites and participate in ICL repair.
Aim 3 attempts to uncover the connection between SLX4 complex and FA pathway in ICL repair and further determine the significance of these repair components in cancer therapy. These studies, together with the ones proposed in Projects 1-3, will provide a framework of ICL repair in humans.
Interstrand crosslinks (ICLs) are the most toxic lesions in the cell and are known to be effective in cancer treatment. Despite extensive studies in the last decade and the identification of many key components in ICL repair, it remains elusive how multiple DNA repair enzymes and pathways are coordinated in vivo to process and repair ICLs. This project focuses on a critical scaffold protein SLX4 and will elucidate how SLX4 acts as a headquarters to direct nucleases and other repair proteins in ICL repair.
|Wang, Hailong; Li, Shibo; Oaks, Joshua et al. (2018) The concerted roles of FANCM and Rad52 in the protection of common fragile sites. Nat Commun 9:2791|
|Tomida, Junya; Takata, Kei-Ichi; Bhetawal, Sarita et al. (2018) FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells. EMBO J 37:|
|Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6|
|Lange, Sabine S; Bhetawal, Sarita; Reh, Shelley et al. (2018) DNA polymerase ? deficiency causes impaired wound healing and stress-induced skin pigmentation. Life Sci Alliance 1:|
|Tian, Yanyan; Shen, Xi; Wang, Rui et al. (2017) Constitutive role of the Fanconi anemia D2 gene in the replication stress response. J Biol Chem 292:20184-20195|
|Klages-Mundt, Naeh L; Li, Lei (2017) Formation and repair of DNA-protein crosslink damage. Sci China Life Sci 60:1065-1076|
|Reh, Wade A; Nairn, Rodney S; Lowery, Megan P et al. (2017) The homologous recombination protein RAD51D protects the genome from large deletions. Nucleic Acids Res 45:1835-1847|
|Takata, Kei-Ichi; Reh, Shelley; Yousefzadeh, Matthew J et al. (2017) Analysis of DNA polymerase ? function in meiotic recombination, immunoglobulin class-switching, and DNA damage tolerance. PLoS Genet 13:e1006818|
|Manandhar, Mandira; Lowery, Megan G; Boulware, Karen S et al. (2017) Transcriptional consequences of XPA disruption in human cell lines. DNA Repair (Amst) 57:76-90|